{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:09:04Z","timestamp":1790824144485,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T00:00:00Z","timestamp":1437091200000},"content-version":"vor","delay-in-days":350,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ajpath.2014.04.013","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T13:18:03Z","timestamp":1401974283000},"page":"2322-2332","source":"Crossref","is-referenced-by-count":19,"title":["Abnormal Splicing of NEDD4 in Myotonic Dystrophy Type 2"],"prefix":"10.1016","volume":"184","author":[{"given":"Mark","family":"Screen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Harald","family":"Jonson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayinka","family":"Raheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Palmio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reijo","family":"Laaksonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terho","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sirito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Krahe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne","family":"Udd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2014.04.013_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.20301","article-title":"Clinical and molecular aspects of the myotonic dystrophies: a review","volume":"32","author":"Machuca-Tzili","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2014.04.013_bib2","series-title":"Genetic Instabilities and Neurological Diseases","first-page":"131","article-title":"Myotonic dystrophy type 2: clinical and genetic aspects","author":"Krahe","year":"2006"},{"key":"10.1016\/j.ajpath.2014.04.013_bib3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","article-title":"Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9","volume":"293","author":"Liquori","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2014.04.013_bib4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1212\/01.wnl.0000333665.01888.33","article-title":"Premutation allele pool in myotonic dystrophy type 2","volume":"72","author":"Bachinski","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2014.04.013_bib5","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/01.WNL.0000065898.61358.09","article-title":"Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM\/DM2","volume":"60","author":"Vihola","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2014.04.013_bib6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ejhg.2011.23","article-title":"Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland","volume":"19","author":"Suominen","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ajpath.2014.04.013_bib7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","article-title":"The myotonic dystrophies: molecular, clinical, and therapeutic challenges","volume":"11","author":"Udd","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ajpath.2014.04.013_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.nmd.2004.01.002","article-title":"New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2)","volume":"14","author":"Sallinen","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2014.04.013_bib9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1086\/421528","article-title":"Insulin receptor splicing alteration in myotonic dystrophy type 2","volume":"74","author":"Savkur","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajpath.2014.04.013_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","article-title":"Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy","volume":"10","author":"Mankodi","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajpath.2014.04.013_bib11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nm.2374","article-title":"Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy","volume":"17","author":"Fugier","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2014.04.013_bib12","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/hmg\/ddr568","article-title":"Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel","volume":"21","author":"Tang","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2014.04.013_bib13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-010-0637-6","article-title":"Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2","volume":"119","author":"Vihola","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2014.04.013_bib14","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ana.23992","article-title":"Splicing biomarkers of disease severity in myotonic dystrophy","volume":"74","author":"Nakamori","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2014.04.013_bib15","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2353\/ajpath.2010.100179","article-title":"Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2","volume":"177","author":"Raheem","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2014.04.013_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijcard.2011.07.048","article-title":"Managing the underestimated risk of statin-associated myopathy","volume":"159","author":"Rallidis","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ajpath.2014.04.013_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clpt.2006.02.013","article-title":"On the mechanisms of statin-induced myopathy","volume":"79","author":"Laaksonen","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2014.04.013_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.nmd.2006.03.010","article-title":"140th ENMC International Workshop: myotonic dystrophy DM2\/PROMM and other myotonic dystrophies with guidelines on management","volume":"16","author":"Udd","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2014.04.013_bib19","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/archneurol.2011.191","article-title":"Laboratory abnormalities in patients with myotonic dystrophy type 2","volume":"68","author":"Heatwole","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ajpath.2014.04.013_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJMc081975","article-title":"SLCO1B1 variants and statin-induced myopathy","volume":"360","author":"Vladutiu","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2014.04.013_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2353\/ajpath.2010.091140","article-title":"Statin therapy and the expression of genes that regulate calcium homeostasis and membrane repair in skeletal muscle","volume":"177","author":"Draeger","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2014.04.013_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5551\/jat.12.121","article-title":"Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins","volume":"12","author":"Morikawa","year":"2005","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.ajpath.2014.04.013_bib23","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1371\/journal.pone.0000097","article-title":"A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle","volume":"1","author":"Laaksonen","year":"2006","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2014.04.013_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cell.2006.11.039","article-title":"NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN","volume":"128","author":"Wang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2014.04.013_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins","volume":"41","author":"Grable-Esposito","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2014.04.013_bib26","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.ATV.0000190608.28704.71","article-title":"Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins","volume":"25","author":"Urso","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2014.04.013_bib27","first-page":"3940","article-title":"The muscle-specific ubiquitin ligase atrogin-1\/MAFbx mediates statin-induced muscle toxicity","volume":"117","author":"Hanai","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2014.04.013_bib28","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1161\/10.1161\/01.ATV.0000194548.11901.a4","article-title":"Mechanisms of statin-induced myopathy: a role for the ubiquitin-proteasome pathway?","volume":"25","author":"Chapman","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2014.04.013_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cell.2006.11.040","article-title":"Ubiquitination regulates PTEN nuclear import and tumor suppression","volume":"128","author":"Trotman","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2014.04.013_bib30","doi-asserted-by":"crossref","first-page":"12620","DOI":"10.1074\/jbc.M109.072280","article-title":"Ubiquitination of PTEN (phosphatase and tensin homolog) inhibits phosphatase activity and is enhanced by membrane targeting and hyperosmotic stress","volume":"285","author":"Maccario","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2014.04.013_bib31","doi-asserted-by":"crossref","first-page":"ra5","DOI":"10.1126\/scisignal.1160940","article-title":"Nedd4 controls animal growth by regulating IGF-1 signaling","volume":"1","author":"Cao","year":"2008","journal-title":"Sci Signal"},{"key":"10.1016\/j.ajpath.2014.04.013_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1096\/fj.06-6665com","article-title":"The ubiquitin-protein ligase Nedd4 targets Notch1 in skeletal muscle and distinguishes the subset of atrophies caused by reduced muscle tension","volume":"21","author":"Koncarevic","year":"2007","journal-title":"FASEB J"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014002715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014002715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T16:13:32Z","timestamp":1597940012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944014002715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0002944014002715"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2014.04.013","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}